Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-19

Clinical Trial Update: Beta Glucan 500 and Biological Age and Immune Age [Phase 2]

View source ↗

Summary

Phase 2 trial results update evaluating Beta Glucan 500 for effects on biological age and immune age; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beta Glucan 500 (beta-glucan 500)

Snippet

Sponsor: OvationLab | Conditions: Aging | Phase 2 | Status: COMPLETED